• Go to navigation
  • Go to content
Patient Health International

You are here

  • Home
  • AstraZeneca medicines
  • Bambec® (bambuterol)

Astrazeneca global websites

  • AstraZeneca Websites

Main navigation

  • Home
  • News & feature articles
  • Body map
  • List of health conditions
  • Insomnia
  • Interactive area
  • Interactive learning
  • About medicines
  • AstraZeneca medicines
  • About clinical trials
  • Glossary
  • Links
  • Sitemap

Bambec® (bambuterol)

Alternative brand (trade) names:

What is Bambec® ?

Bambec belongs to a group of asthma treatments called bronchodilators. It contains bambuterol hydrochloride which, once absorbed into the body, forms the active medicine called terbutaline.

What is Bambec® used for?

Bambec is used to treat asthma and conditions where there is difficulty in breathing due to narrowing of the air passages (bronchospasm and reversible airways obstruction).

How does Bambec® work ?

Bambec forms the active drug terbutaline, which is a bronchodilator:

  • Bronchodilators are medicines that open up the air passages (bronchial tubes) of the lungs.

  • They are used to treat the symptoms of bronchial asthma, chronic bronchitis, emphysema, and other lung diseases.

  • They relieve cough, wheezing, shortness of breath and troubled breathing, by increasing the flow of air through the bronchial tubes.

  • Note that Bambec is not intended to treat acute asthma attacks.

How is Bambec® given ?

Bambec is supplied as tablets and as a liquid medicine. It is given once a day to improve ease of breathing over 24 hours. It is particularly good for people who cannot easily use inhalers, like children and the elderly. Bambec is not intended to treat acute asthma attacks.

Country specific information

To consult your local information.

Any medical information on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. Read more important information.

Back to search

  • Advanced search

Quick links

  • Investor information
  • Press information
  • AstraZeneca US

Page tools

  • Print
  • Bookmark this page

Related links

  • Other countries

List of conditions

AstraZeneca medicines

AstraZeneca International

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2009